Case Series Reports Myocarditis After Second Dose of COVID-19 Vaccine
Seven cases of acute myocarditis, myopericarditis identified in healthy male teens within four days after second Pfizer-BioNTech dose
Declining COVID-19 Vaccination Rates Threaten Biden’s July 4 Goal
United States is averaging fewer than 1 million shots per day, a decline of more than two-thirds from a peak of 3.4 million in April
COVID-19 Symptom Exacerbation Leading Cause of Reencounters
Neurologic illness prior to COVID-19 a predictor for acute-care hospital reencounters within 30 days and four months
CDC Investigating Heart Problems in Teens, Young Adults After COVID-19 Vaccination
Health care providers should watch for unusual heart symptoms among young people who have just received the vaccine
Latin America’s COVID-19 Death Toll Climbs Above 1 Million
Region with only 8 percent of the world's population has accounted for about 29 percent of COVID-19 deaths worldwide
Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study
Study shows that after two doses, the Pfizer vaccine is 88 percent effective in protecting against symptomatic disease from the variant
Thousands of ‘Black Fungus’ Cases Reported in COVID-19 Patients in India
Nearly 9,000 cases of the fungal infection mucormycosis have been reported so far
U.S. COVID-19 Infections, Deaths Drop to Levels Not Seen Since Last Summer
United States reporting about 25,700 new COVID-19 cases daily, a 39 percent decrease from two weeks ago
Approved Vaccines ‘Respond’ to All COVID-19 Variants So Far: WHO
However, unknown variants of the virus could still emerge and be resistant to existing vaccines
